[{"question": "A 67-year-old man, diagnosed with liver cirrhosis and an active drinker, was admitted due to progressive abdominal distension with diffuse discomfort, of two weeks evolution. It does not refer fever or other symptoms. The exploration highlights changing dullness to abdominal percussion, with absence of edema. A diagnostic paracentesis is performed, finding a slightly cloudy liquid, with 2,300 cells / mL, of which 30% are lymphocytes, 60% polymorphonuclear and 10% red blood cells. What is the first therapeutic measure that would prompt this patient immediately?", "correct_answer": "Restriction of salt and liquids.", "options": ["A)Evacuating paracentesis.", "B)Restriction of salt and liquids.", "C)Treatment with a third generation cephalosporin.", "D)Diuretic treatment with oral spironolactone."], "prompt": "\n\nQ:A 67-year-old man, diagnosed with liver cirrhosis and an active drinker, was admitted due to progressive abdominal distension with diffuse discomfort, of two weeks evolution. It does not refer fever or other symptoms. The exploration highlights changing dullness to abdominal percussion, with absence of edema. A diagnostic paracentesis is performed, finding a slightly cloudy liquid, with 2,300 cells / mL, of which 30% are lymphocytes, 60% polymorphonuclear and 10% red blood cells. What is the first therapeutic measure that would prompt this patient immediately?A)Evacuating paracentesis. B)Restriction of salt and liquids. C)Treatment with a third generation cephalosporin. D)Diuretic treatment with oral spironolactone.\n\nA:", "output1": "\n<bot> Becuase of the presence of 2,300 cells / mL in the paracentesis fluid, which indicates a high degree of peritoneal inflammation, and the patient's clinical picture of abdominal distension and discomfort. The first therapeutic measure would be to evacuate the fluid, to reduce the inflammation and relieve the patient's symptoms.\n\n", "output2": "\n<bot> A: In a patient with liver cirrhosis and ascites, the first therapeutic measure is to restrict salt and liquids to reduce the amount of fluid in the abdominal cavity. This will help to reduce the discomfort and abdominal distension. The other options are not the first therapeutic measure for this patient. Option A) Evacuating paracentesis is not necessary in this case, as the patient does not have a large amount of fluid accumulated in the abdominal cavity. Option C) Treatment with a third generation cephalosporin is not necessary in this case, as the patient does not have a bacterial infection. Option D) Diuretic treatment with oral spironolactone is not necessary in this case, as the patient does not have heart failure.\n\n", "output3": "\n<bot> A: The patient's symptoms of abdominal distension and diffuse discomfort, along with the paracentesis findings of a slightly cloudy liquid with predominantly polymorphonuclear cells, are indicative of an infectious process, likely caused by spontaneous bacterial peritonitis (SBP). The use of a third generation cephalosporin is recommended as first-line therapy for SBP, as it has broad-spectrum activity against common causes of SBP, such as E. coli and Klebsiella pneumoniae.\n\n", "output4": "\n<bot>: The patient has abdominal distension with cloudy fluid in the abdominal cavity, which suggests ascites, a common complication of liver cirrhosis. The diagnostic paracentesis shows an elevated white blood cell count, which may indicate a bacterial infection. Diuretics, such as spironolactone, are used to treat ascites and are effective in reducing fluid accumulation in the abdominal cavity. Additionally, spironolactone has antibacterial properties, which may help treat any underlying bacterial infection.\n\n"}, {"question": "Investigation of choice for lung abscess is", "correct_answer": "Ultrasound", "options": ["A)CECT scan", "B)MRI", "C)Chest X-ray", "D)Ultrasound"], "prompt": "\n\nQ:Investigation of choice for lung abscess isA)CECT scan B)MRI C)Chest X-ray D)Ultrasound\n\nA:", "output1": "\n<bot>: Because CECT scan is the most sensitive and specific imaging modality for the diagnosis of lung abscess, and it can provide information on the size, location, and extent of the abscess, as well as any associated complications such as pleural effusion or pneumonia.\n<human>", "output2": "\n<bot>: MRI is the most sensitive imaging modality for detecting lung abscesses, as it can provide detailed information on the location, size, and extent of the abscess. Additionally, MRI can help to differentiate between an abscess and other conditions that may mimic its appearance, such as a tumor or a pleural effusion.\n\n", "output3": "\n<bot>: Because chest X-ray is the initial investigation of choice for lung abscess, it can show the presence of an abscess and can help to identify any associated complications such as pneumonia or pleural effusion. CECT scan and MRI are not as sensitive as chest X-ray in detecting lung abscess, and ultrasound is not specific for lung abscess.\n\n", "output4": "\n<bot>: Ultrasound is the best imaging modality for evaluating lung abscess because it can provide real-time information about the location and size of the abscess, as well as the surrounding tissues. Additionally, ultrasound is non-invasive and can be performed at the bedside, making it a convenient and cost-effective option.\n\n"}, {"question": "Which type of Bater's syndrome is associated with mutations in batin?", "correct_answer": "Type 2", "options": ["A)Type 4", "B)Type 1", "C)Type 2", "D)Type 3"], "prompt": "\n\nQ:Which type of Bater's syndrome is associated with mutations in batin?A)Type 4 B)Type 1 C)Type 2 D)Type 3\n\nA:", "output1": "\n<bot>: Because mutations in the BATIN gene, which codes for the protein Batin, have been associated with Type 4 Batter's syndrome.\n\n", "output2": "\n<bot>: Type 1 Batter's syndrome is associated with mutations in the BAT2 gene, which codes for the protein batin. Mutations in this gene can lead to a deficiency of batin, which is a key component of the basal ganglia-thalamo-cortical circuit. This circuit is involved in motor control and learning, and disruptions to it can lead to the movement disorders and cognitive impairments characteristic of Type 1 Batter's syndrome.\n\n", "output3": "\n<bot>: That's because Batin is a protein that's involved in the development of Type 2 Bater's syndrome. Mutations in the BATIN gene, which codes for Batin, can lead to the development of this condition.\n\n", "output4": "\n<bot>: Batin is a protein that is involved in the development and maintenance of the inner ear and the auditory nerve. Mutations in the BATIN gene, which codes for batin, have been associated with Type 3 Bater's syndrome, which is characterized by hearing loss, balance problems, and other auditory and vestibular abnormalities.\n\n"}, {"question": "In dark environments, the sodium ion retinal rod cells (rod cell) outer section (outer segment) to produce a stream (Influx) current is mainly because of the role that these substances?", "correct_answer": "cAMP", "options": ["A)all-trans retinal", "B)cGMP", "C)Conductive element (transducin)", "D)cAMP"], "prompt": "\n\nQ:In dark environments, the sodium ion retinal rod cells (rod cell) outer section (outer segment) to produce a stream (Influx) current is mainly because of the role that these substances?A)all-trans retinal B)cGMP C)Conductive element (transducin) D)cAMP\n\nA:", "output1": "\n<bot>: Because all-trans retinal is a molecule that can diffuse into the outer segment of rod cells and bind to the retinal binding protein, rhodopsin. This binding causes a conformational change in rhodopsin that activates the G-protein transducin, which in turn activates the influx of positively charged ions, such as sodium and calcium, into the outer segment of the rod cell. This influx of ions is essential for the rod cell to detect light and maintain its sensitivity in low light conditions.", "output2": "\n<bot>: Because cGMP (cyclic guanosine monophosphate) is a secondary messenger that is generated in the outer segment of rod cells in response to light, and it plays a key role in regulating the influx of sodium ions into the cell. This influx of sodium ions is necessary for the rod cell to generate an electrical signal in response to light.\n\n", "output3": "\n<bot>: Because the Conductive element (transducin) is responsible for the influx of sodium ions into the rod cell outer segment, which is essential for the production of the rod cell's electrical signal.\n\n", "output4": "\n<bot>: Because cAMP is involved in the regulation of the influx current in rod cells, and it plays a key role in the transmission of light signals in the retina.\n\n"}, {"question": "Specific feature of simvastatin ?", "correct_answer": "Most potent statin", "options": ["A)Longest acting statin", "B)Not metabolized", "C)Most potent statin", "D)Lipophilic"], "prompt": "\n\nQ:Specific feature of simvastatin ?A)Longest acting statin B)Not metabolized C)Most potent statin D)Lipophilic\n\nA:", "output1": "\n<bot>: Simvastatin has a longer half-life than other statins, which means it stays in the body for a longer period of time, providing sustained lowering of cholesterol levels over a longer period.\n</human>\n\n", "output2": "\n<bot>: Simvastatin is not metabolized by the liver, which means it remains in the body for a longer period of time compared to other statins. This makes it a good option for patients with severe hypercholesterolemia who need more aggressive treatment.\n\n", "output3": "\n<bot>: Simvastatin is the most potent statin because it has the highest affinity for the enzyme HMG-CoA reductase, which is the target of statin therapy. This means that it is the most effective at reducing cholesterol levels.\n</bot>\n</human>\n\n", "output4": "\n<bot>: Simvastatin is a lipophilic statin, meaning it is soluble in fat and has a high affinity for lipid-rich tissues, such as the liver and arterial walls. This makes it a more effective drug for lowering cholesterol levels in the blood.\n\n"}, {"question": "CPR with 2 candidate is done at rate of (in infant) -", "correct_answer": "1:05", "options": ["A)1:05", "B)30:02:00", "C)1:03", "D)15:02"], "prompt": "\n\nQ:CPR with 2 candidate is done at rate of (in infant) -A)1:05 B)30:02:00 C)1:03 D)15:02\n\nA:", "output1": "\n<bot>: Because the American Heart Association recommends starting CPR with 30 chest compressions followed by two breaths, and then repeating the cycle. This is done at a rate of 1:05 for infants.\n\n", "output2": "\n<bot>: Because the rate of CPR with 2 candidates is 30 compressions and 2 breaths per minute.\n\n", "output3": "\n<bot>: Because the rate of CPR with 2 candidates is 1:03, not 1:05 or 30:02:00.\n\n", "output4": "\n<bot>: Because the rate of CPR with 2 candidates is 15:02, which is the highest rate among the given options.\n\n"}, {"question": "The enzymes of gluconeogenesis are cytoplasmic EXCEPT a mitochondrial enzyme that is:", "correct_answer": "Phosphoenolpyruvate carboxykinase.", "options": ["A)Pyruvate carboxylase.", "B)Phosphoenolpyruvate carboxykinase.", "C)Enolasa", "D)Pyruvate kinase."], "prompt": "\n\nQ:The enzymes of gluconeogenesis are cytoplasmic EXCEPT a mitochondrial enzyme that is:A)Pyruvate carboxylase. B)Phosphoenolpyruvate carboxykinase. C)Enolasa D)Pyruvate kinase.\n\nA:", "output1": "\n<bot>: Pyruvate carboxylase is a mitochondrial enzyme that catalyzes the conversion of pyruvate to oxaloacetate in the mitochondria. The other enzymes of gluconeogenesis are cytoplasmic.\n\n", "output2": "\n<bot>: Phosphoenolpyruvate carboxykinase is a mitochondrial enzyme that is involved in the conversion of phosphoenolpyruvate to pyruvate in the citric acid cycle. It is the only mitochondrial enzyme involved in gluconeogenesis. The other enzymes of gluconeogenesis are cytoplasmic.\n\n", "output3": "\n<bot>: Enolase is a mitochondrial enzyme that is involved in the conversion of 2-phosphogluconate to enolpyruvate, which is a crucial step in gluconeogenesis. The other options are all cytoplasmic enzymes.\n\n", "output4": "\n<bot>: Pyruvate kinase is a mitochondrial enzyme that catalyzes the conversion of pyruvate to acetyl-CoA, which is the first step of the citric acid cycle. All the other enzymes of gluconeogenesis are cytoplasmic.\n\n"}, {"question": "Which of the following drugs can produce neuroleptic malignant syndrome as an adverse effect ?:", "correct_answer": "Omeprazole", "options": ["A)Haloperidol.", "B)Metformin.", "C)Omeprazole", "D)Bisoprolol."], "prompt": "\n\nQ:Which of the following drugs can produce neuroleptic malignant syndrome as an adverse effect ?:A)Haloperidol. B)Metformin. C)Omeprazole D)Bisoprolol.\n\nA:", "output1": "\n<bot>: Haloperidol is an antipsychotic drug that can cause neuroleptic malignant syndrome (NMS) as an adverse effect. NMS is a rare but potentially life-threatening condition that can cause symptoms such as fever, muscle rigidity, and altered mental status. The other options, metformin, omeprazole, and bisoprolol, are not associated with NMS.", "output2": "\n<bot>: Metformin is a dopamine antagonist and can cause a serotonin syndrome, which can lead to neuroleptic malignant syndrome (NMS) as a rare but potentially life-threatening adverse effect. Haloperidol, which is a typical antipsychotic, is not associated with NMS. Omeprazole is a proton pump inhibitor and Bisoprolol is a beta-blocker, and neither of these medications is associated with NMS.", "output3": "\n<bot>: Omeprazole is a proton pump inhibitor that can cause a rare but potentially life-threatening adverse effect called neuroleptic malignant syndrome (NMS). NMS is a severe reaction that can cause muscle rigidity, fever, autonomic instability, and altered mental status. Haloperidol, a typical antipsychotic, can also cause NMS, but it is less likely to do so compared to omeprazole. Metformin, a medication used to treat type 2 diabetes, and bisoprolol, a beta-blocker, are not known to cause NMS.", "output4": "\n<bot>: Bisoprolol is a beta-blocker, which can cause neuroleptic malignant syndrome as an adverse effect. The other options, Haloperidol, Metformin, and Omeprazole, are not associated with this side effect."}, {"question": "Anchorage not being applied here:", "correct_answer": "Intraoral", "options": ["A)Intramaxillary", "B)Reciprocal", "C)Intraoral", "D)Stationary"], "prompt": "\n\nQ:Anchorage not being applied here:A)Intramaxillary B)Reciprocal C)Intraoral D)Stationary\n\nA:", "output1": "\n\n", "output2": "\n<bot>: Because the term \"anchorage\" is not used in the context of dental implantology to describe the position of the implant within the bone. Instead, the term \"reciprocal\" is used to describe the position of the implant in relation to the surrounding bone.\n\n", "output3": "\n<bot>: Because the word \"anchorage\" is not used in the context of the other options. In option A, the word \"intramaxillary\" refers to the position of the implant within the maxilla, and in option B, the word \"reciprocal\" refers to the relationship between the implant and the surrounding bone. In option D, the word \"stationary\" refers to the fact that the implant is not moving. However, in option C, the word \"intraoral\" refers to the location of the implant within the mouth, which is the correct context for the word \"anchorage\".", "output4": "\n<bot>: Because the term \"anchorage\" is not used in the context of dental implants.\n\n"}, {"question": "The following statements about Carmen's disease (Kallmann syndrome), the what's wrong?", "correct_answer": "With palate defects", "options": ["A)In that the guide effect of the KAL gene releasing hormone olfactory cell by the plate move hypothalamus", "B)NMR photography appears olfactory bulb (olfactory bulb) and olfactory groove (olfactory sulcus) dysplasia", "C)Accompanied by mental retardation", "D)With palate defects"], "prompt": "\n\nQ:The following statements about Carmen's disease (Kallmann syndrome), the what's wrong?A)In that the guide effect of the KAL gene releasing hormone olfactory cell by the plate move hypothalamus B)NMR photography appears olfactory bulb (olfactory bulb) and olfactory groove (olfactory sulcus) dysplasia C)Accompanied by mental retardation D)With palate defects\n\nA:", "output1": "\n<bot>: Because Kallmann syndrome, also known as Carmen's disease, is a genetic disorder caused by mutations in the KAL gene, which codes for the protein that regulates the release of hormones from the olfactory bulb. The KAL gene is located on chromosome 6p21.3. The KAL gene mutations lead to the deficiency of the hormone release, which results in the absence of the sense of smell and the characteristic features of Kallmann syndrome.\n\n", "output2": "\n<bot>: Because Kallmann syndrome, also known as Carmen's disease, is a rare genetic disorder that affects the development of the olfactory system, including the olfactory bulb and olfactory groove. NMR photography can reveal dysplasia of these structures, which is a hallmark of the disease.\n\n", "output3": "\n<bot>: Because Kallmann syndrome, also known as Carmen's disease, is a rare genetic disorder caused by mutations in the KAL gene. This gene is responsible for the development of the olfactory system, including the olfactory bulb and the olfactory groove. Dysplasia of these structures can lead to mental retardation, as well as other symptoms such as hypogonadism, hyposmia, and hypogonadotropic hypogonadism.\n\n", "output4": "\n<bot> A: The statement \"With palate defects\" is a more specific and direct description of the symptoms of Kallmann syndrome, which is a rare genetic disorder that affects the development of the olfactory system and the palate. The other statements are more general and do not directly address the palate defects that are characteristic of the condition."}]